(2) significant increase of serotype 19A (from 1.6% to 14.8%) and less important increase of serotype 3 (from 10.5% to 14.5%) and non-vaccine serotypes (NVT) (from 21.4% to 38.4%) non-significant; and (3) meningitis and non-meningitis multidrug resistant isolates associated with serotype...
We aim was to estimate the difference of costs and expected cases from serotypecoverage of the 13-valent pneumococcal conjugated vaccine (PCV13) and 10-valentpneumococcal conjugated vaccine (PCV10) in the population under 5 years of agein Colombia, using a deterministic model. We considered the ...
BACKGROUND As pneumococci evolve under vaccine, antimicrobial and other selective pressures, it is important to track isolates covered by established (PCV10, PCV13 and PPSV23) and new (PCV15 and PCV20) vaccine formulations.OBJECTIVES To compare invasive pneumococcal disease (IPD) isolates from se...
While there were more children of Ma¯ori descent in the PCV10-vaccinated cohort than the PCV7-vaccinated cohort (Table 3), there was no difference in the proportion of otitis-prone versus non-otitis-prone Ma¯ori children in each vaccine group: PCV7-vaccinated otitis-prone Ma¯ori ...
Therefore, vaccine uptake must be high enough to be able to affect serotype distribution/IPD incidence rates at the population level [18,19] and to represent the experience of countries with high coverage. It also serves to help eliminate heterogeneous results due to coverage to enable focus on...
Our overall objective was therefore to evaluate safety and immunogenicity of a combination PCV schedule of PHiD-CV10 (S) given at 1–2–4 months plus PCV13 (P) given at 6 months (SSSP) compared to either vaccine alone when given at 2–4-6 months (_SSS or _PPP). The aim being to...
The 10-valent pneumococcal vaccine (PCV10) has been introduced in the national immunization program (2+1 schedule: 6 and 10 weeks, and 9 months) in Nepal since 2015. The impact of PCV10 on hospital admission due to pneumonia is not well known in Nepal. METHODS. A cross-sectional study ...
While the PCV10 vaccine was introduced in Pakistan in October 2012, data regarding the impact of the vaccine on the population dynamics of Streptococcus pneumoniae in Pakistan remain obscure. Using whole genome sequencing of 190 isolates (nasopharyngeal carriage=75, disease=113,unknown sites=2) ...
Dns-PCV vaccine The invention relates to immunogenic preparations or vaccines comprising, on the one hand, a plasmid encoding and expressing a gene from PCV, in particular selected from the group consisting of ORF1 of PCV-2, ORF2 of PCV-2, ORF1 of PCV-1... JC Audonnet,M Bublot,E ...
vaccine (PCV13), contains the seven serotypes in PCV7, five additional serotypes from PPSV23, and a new serotype not contained in PPSV23 or PCV7... CC Daniels,PD Rogers,CM Shelton - 《J Pediatr Pharmacol Ther》 被引量: 45发表: 2016年 Immunogenicity and safety of the 13-valent pneu...